Literature DB >> 25387500

Targetoid hemosiderotic hemangioma - Case report.

Priscila Kakizaki1, Neusa Yuriko Sakai Valente1, Daniele Loureiro Mangueira Paiva2, Fernando Luiz Teixeira Dantas1, Sheila Viana Castelo Branco Gonçalves3.   

Abstract

Targetoid Hemosiderotic Hemangioma, also known as Hobnail Hemangioma, is a lesion of vascular origin, probably lymphatic. The most common clinical feature is a solitary violaceous papule surrounded by a pale, thin area and a peripheral ecchymotic ring, simulating a target. Histopathologically, there is a biphasic pattern, with dilated vessels in the superficial dermis and pseudoangiosarcomatous pattern in the deep dermis, and endothelial cells with hobnail morphology. A simple excision is curative. We report a rare case of Targetoid Hemosiderotic Hemangioma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25387500      PMCID: PMC4230664          DOI: 10.1590/abd1806-4841.20143264

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

Review 1.  Targetoid haemosiderotic haemangioma: dermoscopic monitoring of three cases and review of the literature.

Authors:  M T Sahin; M A Demir; K Gunduz; S Ozturkcan; A Türel-Ermertcan
Journal:  Clin Exp Dermatol       Date:  2005-11       Impact factor: 3.470

2.  Hobnail hemangioma: a pseudomalignant vascular lesion with a reappraisal of targetoid hemosiderotic hemangioma.

Authors:  L Guillou; E Calonje; P Speight; J Rosai; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1999-01       Impact factor: 6.394

Review 3.  Targetoid hemosiderotic hemangioma- a dynamic vascular tumor: report of 3 cases with episodic and cyclic changes and comparison with solitary angiokeratomas.

Authors:  J A Carlson; S Daulat; H P Goodheart
Journal:  J Am Acad Dermatol       Date:  1999-08       Impact factor: 11.527

4.  Hobnail hemangioma reclassified as superficial lymphatic malformation: a study of 52 cases.

Authors:  Felicidade Trindade; Heinz Kutzner; Óscar Tellechea; Luis Requena; Isabel Colmenero
Journal:  J Am Acad Dermatol       Date:  2011-08-06       Impact factor: 11.527

5.  Trauma-induced simulator of targetoid hemosiderotic hemangioma.

Authors:  L J Christenson; M S Stone
Journal:  Am J Dermatopathol       Date:  2001-06       Impact factor: 1.533

6.  Targetoid hemosiderotic hemangiomas (hobnail hemangiomas) are vascular lymphatic malformations: a study of 12 pediatric cases.

Authors:  Rola Al Dhaybi; Christina Lam; Afshin Hatami; Julie Powell; Catherine McCuaig; Victor Kokta
Journal:  J Am Acad Dermatol       Date:  2011-07-27       Impact factor: 11.527

7.  Hobnail hemangioma ("targetoid hemosiderotic hemangioma"): clinicopathologic and immunohistochemical analysis of 62 cases.

Authors:  T Mentzel; T A Partanen; H Kutzner
Journal:  J Cutan Pathol       Date:  1999-07       Impact factor: 1.587

8.  Hobnail haemangioma associated with the menstrual cycle.

Authors:  J A Ortiz-Rey; A González-Ruiz; P San Miguel; C Alvarez; B Iglesias; I Antón
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-05       Impact factor: 6.166

9.  Targetoid hemosiderotic hemangioma.

Authors:  D J Santa Cruz; J Aronberg
Journal:  J Am Acad Dermatol       Date:  1988-09       Impact factor: 11.527

10.  Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas.

Authors:  Folker E Franke; Klaus Steger; Alexander Marks; Heinz Kutzner; Thomas Mentzel
Journal:  J Cutan Pathol       Date:  2004-05       Impact factor: 1.587

  10 in total
  2 in total

1.  Composite Hemangioendothelioma: Report of a Rare Case.

Authors:  Amoolya Bhat; Vijaya Chowdappa
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  High-Fat Diet and Alcohol Intake Promotes Inflammation and Impairs Skin Wound Healing in Wistar Rats.

Authors:  Daiane Figueiredo Rosa; Mariáurea Matias Sarandy; Rômulo Dias Novaes; Mariella Bontempo Freitas; Maria do Carmo Gouveia Pelúzio; Reggiani Vilela Gonçalves
Journal:  Mediators Inflamm       Date:  2018-07-24       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.